Roivant Sciences Ltd.
ROIVNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ROIV. That does not mean none is planned.
Get an email about ROIV's next catalysts
Track Roivant Sciences (ROIV) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
ROIV Earnings Report
EPS Est: $-0.52 | FQ end Sep/2026 | Call: bmo
How ROIV's past catalysts played out
Market Overview
Stock performance and key metrics
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Gimsilumab | Phase 2 | COVID-19 | - | - |
treatment of adults with dermatomyositis
1 drug in this indication
dermatomyositis in adults
1 drug in this indication
non-infectious uveitis (NIU)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Roivant Sciences Ltd.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Roivant Sciences Ltd.'s (ROIV) pipeline across Phase 2. Its lead program is Gimsilumab (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Roivant Sciences Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Roivant Sciences Ltd. (ROIV) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ROIV biotech catalysts?→
Add ROIV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Roivant Sciences Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.